In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice

被引:33
作者
Fu, Cai Y. [1 ,2 ]
Zhao, You L. [2 ]
Dong, Li [3 ]
Chen, Qiang [2 ]
Ni, Jing M. [3 ]
Wang, Rui [1 ,2 ]
机构
[1] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chinese Med & Mol Pharmacol, Kowloon, Hong Kong, Peoples R China
[2] Lanzhou Univ, Inst Biochem & Mol Biol, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China
[3] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China
基金
中国国家自然科学基金;
关键词
human HK-1 and its truncated form h HK-1(4-11); SR140333 and SR48968; opioid receptors antagonists; a competitive antagonist at GABA(A) receptors; antinociception;
D O I
10.1016/j.bbi.2007.12.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Human hemokinin-1 (h HK-1) and its truncated form h HK-1(4-11) are mammalian tachykinin peptides encoded by the recently identified TAC4 gene in human, and the biological functions of these peptides have not been well investigated. In the present study, an attempt has been made to investigate the effects and mechanisms of action of h HK-1 and h HK-1(4-11) in pain modulation at the supraspinal level in mice using the tail immersion test. Intracerebroventricular (i.c.v.) administration of h HK-1 (0.3, 1, 3 and 6 nmol/mouse) produced a dose- and time-related antinociceptive effect. This effect was significantly antagonized by the NK1 receptor antagonist SR140333, but not by the NK2 receptor antagonist SR48968, indicating that the analgesic effect induced by i.c.v. h HK-1 is mediated through the activation of NK1 receptors. Interestingly, naloxone, beta-funaltrexamine and naloxonazine, but not naltrindole and nor-bin-altorphimine, could also block the analgesic effect markedly, suggesting that this effect is related to descending mu opioidergic neurons (primary mu(1) subtype). Human HK-1(4-11) could also induce a dose- and time-dependent analgesic effect after i.c.v. administration, however, the potency of analgesia was less than h HK-1. Surprisingly, SR140333 could not modify this analgesic effect, suggesting that this effect is not mediated through the NK1 receptors like h HK-1. SR48968 could modestly enhance the analgesic effect induced by h HK-1(4-11), indicating that a small amount of h HK-1(4-11) may bind to NK2 receptors. Furthermore, none of the opioid receptor (OR) antagonists could markedly block the analgesia of h HK-1(4-11), suggesting that the analgesic effect is not mediated through the descending opioidergic neurons. Blocking of delta ORs significantly enhanced the analgesia, indicating that delta OR is a negatively modulatory factor in the analgesic effect of h HK-1(4-11). It is striking that bicuculline (a competitive antagonist at GABA(A) receptors) effectively blocked the analgesia induced by h HK-1(4-11), suggesting that this analgesic effect is mediated through the descending inhibitory GABAergic neurons. The novel mechanism involved in the analgesic effect of h HK-1 (4-11), which is different from that of h HK-1, may pave the way for a new strategy for the investigation and control of pain. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:850 / 860
页数:11
相关论文
共 46 条
[1]
BARTOLINI A, 1981, BRIT J PHARMACOL, V72, P156
[2]
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1 [J].
Bellucci, F ;
Carini, F ;
Catalani, C ;
Cucchi, P ;
Lecci, A ;
Meini, S ;
Patacchini, R ;
Quartara, L ;
Ricci, R ;
Tramontana, M ;
Giuliani, S ;
Maggi, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :266-274
[3]
Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: A pharmacological and functional study [J].
Berger, A ;
Paige, CJ .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 164 (1-2) :48-56
[4]
CASCIERI MA, 1992, MOL PHARMACOL, V41, P1096
[5]
Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils [J].
Duffy, RA ;
Hedrick, JA ;
Randolph, G ;
Morgan, CA ;
Cohen-Williams, ME ;
Vassileva, G ;
Lachowicz, JE ;
Laverty, M ;
Maguire, M ;
Shan, LS ;
Gustafson, E ;
Varty, GB .
NEUROPHARMACOLOGY, 2003, 45 (02) :242-250
[6]
Effect of intrathecal administration of hemokinin-1 on the withdrawal response to noxious thermal stimulation of the rat hind paw [J].
Endo, D ;
Ikeda, T ;
Ishida, Y ;
Yoshioka, D ;
Nishimori, T .
NEUROSCIENCE LETTERS, 2006, 392 (1-2) :114-117
[7]
FONG TM, 1992, J BIOL CHEM, V267, P25668
[8]
DUAL ACTIONS OF SUBSTANCE-P ON NOCICEPTION - POSSIBLE ROLE OF ENDOGENOUS OPIOIDS [J].
FREDERICKSON, RCA ;
BURGIS, V ;
HARRELL, CE ;
EDWARDS, JD .
SCIENCE, 1978, 199 (4335) :1359-1362
[9]
Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level [J].
Fu, Cai-Yun ;
Tang, Xiao-Long ;
Yang, Qi ;
Chen, Qiang ;
Wang, Rui .
BEHAVIOURAL BRAIN RESEARCH, 2007, 184 (01) :39-46
[10]
Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: Systemic study in anesthetized rats [J].
Fu, Cai-Yun ;
Kong, Zi-Qing ;
Long, Yuan ;
Chen, Qiang ;
Wang, Rui .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 572 (2-3) :175-181